Cargando…

DNA Sequencing Predicts 1st-Line Tuberculosis Drug Susceptibility Profiles

BACKGROUND: The World Health Organization recommends universal drug susceptibility testing for Mycobacterium tuberculosis complex to guide treatment decisions and improve outcomes. We assessed whether DNA sequencing can accurately predict antibiotic susceptibility profiles for first-line anti-tuberc...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121966/ https://www.ncbi.nlm.nih.gov/pubmed/30280646 http://dx.doi.org/10.1056/NEJMoa1800474

Ejemplares similares

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
por: Schwalb, Alvaro, et al.
Publicado: (2021)

The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia
por: Maladan, Yustinus, et al.
Publicado: (2021)

First Susceptibility Testing of Mycobacterium tuberculosis for Second-line Anti-tuberculosis Drugs in Ghana
por: Kato, Tomoko, et al.
Publicado: (2014)

Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization
por: Wood, Hillary N., et al.
Publicado: (2019)

Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis
por: Gygli, Sebastian M., et al.
Publicado: (2019)

Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis
por: Kim, Hyejin, et al.
Publicado: (2013)

Evaluation of drug susceptibility profile of Mycobacterium tuberculosis Lineage 1 from Brazil based on whole genome sequencing and phenotypic methods
por: Guimarães, Arthur Emil dos Santos, et al.
Publicado: (2021)

Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction
por: Nilgiriwala, Kayzad, et al.
Publicado: (2023)

Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance
por: Bobadilla-del Valle, Miriam, et al.
Publicado: (2015)

Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
por: Walker, Timothy M, et al.
Publicado: (2015)

Universal drug-susceptibility testing of first-line drugs to preserve their efficacy: An essential strategy to defeat tuberculosis
por: Dev Bhattarai, Madhur
Publicado: (2023)

DNA sequence properties that predict susceptibility to epiallelic switching
por: Catoni, Marco, et al.
Publicado: (2017)

Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells
por: Blischak, John D., et al.
Publicado: (2017)

Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai
por: Chen, Yong, et al.
Publicado: (2016)

Clinical Whole-Genome Sequencing Assay for Rapid Mycobacterium tuberculosis Complex First-Line Drug Susceptibility Testing and Phylogenetic Relatedness Analysis
por: Shaw, Bennett, et al.
Publicado: (2023)

Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis
por: Idh, Jonna, et al.
Publicado: (2012)

Evaluation of BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to First-Line Drugs in China
por: Zhao, Ping, et al.
Publicado: (2014)

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
por: Mpagama, Stellah G, et al.
Publicado: (2013)

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China
por: Lin, Shufang, et al.
Publicado: (2021)

Mycobacterium tuberculosis Transcriptome Profiling in Mice with Genetically Different Susceptibility to Tuberculosis
por: Skvortsov, T.A., et al.
Publicado: (2013)

Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs
por: Lee, Sangyeop, et al.
Publicado: (2019)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran
por: Mansoori, Noormohamad, et al.
Publicado: (2020)

Treatment of Drug Susceptible Pulmonary Tuberculosis
por: Shin, Hong-Joon, et al.
Publicado: (2015)

New insights on tuberculosis transmission dynamics and drug susceptibility profiles among the prison population in Southern Brazil based on whole-genome sequencing
por: Anselmo, Lívia Maria Pala, et al.
Publicado: (2023)

2058. Comparison of Drug Resistance Rates of Mycobacterium tuberculosis by the Conventional Drug Susceptibility Test and Sequencing Method
por: Kim, Han-Sung
Publicado: (2018)

Comparative Utility of Genetic Determinants of Drug Resistance and Phenotypic Drug Susceptibility Profiling in Predicting Clinical Outcomes in Patients With Multidrug-Resistant Mycobacterium tuberculosis
por: Che, Yang, et al.
Publicado: (2021)

Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
por: Sharaf Eldin, Ghada S, et al.
Publicado: (2011)

Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
por: Sanchotene, Karine O., et al.
Publicado: (2008)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2022)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya
por: Kerubo, Glennah, et al.
Publicado: (2016)

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres
por: MacLean, Emily Lai-Ho, et al.
Publicado: (2023)

Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia
por: Welekidan, Letemichael Negash, et al.
Publicado: (2021)

Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
por: Lisdawati, Vivi, et al.
Publicado: (2015)

Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran
por: Daneshfar, Sara, et al.
Publicado: (2022)

Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
por: Solans, Belén P, et al.
Publicado: (2023)

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
por: Nahid, Payam, et al.
Publicado: (2011)

Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosis
por: Chang, Adrienne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ifmfru7sjumujsfn1ensh5kmp8